ÃâÒßѧÊÔÌâ
m=y,_Pz>U Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
Ai_|)
1. Fas(CD95)/FasL
17[t_T&Ak9 2. common chain of cytokine receptor
h'q0eqYeu) 3 . TCR/CD3 complex
!vo '8r?& 4. negaive selection of thymocytes
&8YI)G% 5. artificial active immune
t:j07 ,1~ 6. anti-idiotypic
BHBT=,sI 7. IgSF
'*{Rn
7B5 8. Integrin
wTAEJ{p 9. chemokine
w#bbm'j7r 10. B7/CD28
n7!Lwq2 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
snzH}$
Ls 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
1B]wSvP@ 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
y42T.oK8c 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
]` Gz_e 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
LFM5W&?
f7AJSHe 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
z8[|LF-dx µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
|q b92|? Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
2
]6u
Be 1. B7/CD28
JRs[%w`kD 2. Th1 subset
q@yabuN@,j 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
k.f:nv5JO 4. antibody affinity maturation
aZ0iwMK 5. AP-1
X1QZEl 6. single chain variable fragment£¨ScFv£©
b6M)qt9R 7. NK cell receptor
:h dh$}y 8. Zinkernagel-Doherty phenomenon
e$|)wOwU 9. Ig fold
|y=F (6Z 10. CD40/CD40L
(j
Q6~1 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
D_kzR
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
8pt
<)Rs} 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
`%:(IGxz 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
P[K
T Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
~4gKA
D 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
l'8wPmy%N 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
m|gd9m$,? 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
5!fW&OiY Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
N>\?Aeh £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
V!tBipX% Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
-\v8i.w0 1.Co-stimulators (or co-stimulating molecules)
RIx6& 7$ 2.NK-kB
)f&]H} 3.Immunoglobulin superfamily
Av4E?@R 4.antigen-presenting cell (APC)
>&z+ih 5.death domain
"$YLU}S9 6.CCR and CXCR
nL~
b 7.Lectin (or mitogen)
}-iOYSn 8.Clusters of differentiation, CD)
K7Tell\` 9.B7 family
GQWTQIl] 10.Cytotoxic T lymphocyte, CTL)
1"PE@!] 11.IL-15 and IL-15 receptor (IL-15R)
Uwa1)Lwn 12.MHC restriction
=LA@E&,j 13.Affinity-chromatography
S3wH
M 14.Cyctosprin A, CsA
YNk|UwJi 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
?QVI'R:Z? ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
=1Jo-!{{ 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
}Cf[nGh|B 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
@U5>w\ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
)Cfrqe1^ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
f
d5~'2 ÃâÒßѧרҵ£º
LXl! !i% 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
n3,wwymQ Ïû»¯ÄÚ¿Æ£º
i(rY'o2 BN 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
Y.#+Yh[ ѪҺ²¡Ñ§×¨Òµ£º
[N)M]u 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
$S{j}74[ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
W -&5
v (רҵ»ù´¡: ÃâÒßѧ)
Df^S77&c! Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
?Pc3*. 1. ADCC(antibody dependent cell-mediated cytotoxicity)
c
@R6p+ 2. »·æß¾úËØ(cyclosporin)
qI@_ 3. KIR(killer cell inhibitory receptor)
Ymom 0g+f 4. HLDA(human leucocyte differentiation antigen)
w4a7c 5. Interleukin 18(IL-18)
6Tnzg`0I 6. ÕûºÏËØ(integrin)
oJ:J'$W( 7. Fas/FasL
ba13^;fm# 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
T:$_1I $ 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
Q2Rj0E` 10. Th1/Th2
pkx>6(Y 11. »ùÒòÒßÃç(DNAÒßÃç)
_(foJRr 12. chemokines and chemokine receptor
6Y^o8R 13. ÃâÒßÄÍÊÜ
$!Tw`O 14. ¹²´Ì¼¤·Ö×Ó
8vK&d> 15. ËÀÍö½á¹¹Óò(death domain)
r8rR _M{P ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
cx}-tj"m- 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
0J~4
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
)w-?|2-w5 £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
s? Kn,6Y £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
ZtVa*xl £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
kns]P<g £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
/
Ny&;Y 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
\~PFD%]:3 Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
*rLs!/[Z_ ÎÊ´ðÌâ(ÿÌâ25·Ö)
,ME9<3
Ac 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
~6tY\6$9f 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
zlfm})+G 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
W=!f 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£